These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Novel oral anticoagulants--issues in clinical practice].
    Author: Hohmann C, Neumann-Haefelin T, Radziwill R, Benöhr P.
    Journal: Med Monatsschr Pharm; 2015 Oct; 38(10):374-85; quiz 387-8. PubMed ID: 26731855.
    Abstract:
    The novel oral anticoagulants (NOAC) dabigatran, apixaban, edoxaban and rivaroxaban target either thrombin or factor Xa for the prevention and treatment of thrombosis. A short introduction of the main indications for an oral anticoagulation is followed by the pharmacology of each drug, their effectiveness, selected drug-drug interactions and adverse drug events, especially bleeding. The article represents clinical aspects for the perioperative management, the possibilities for monitoring of each drug, the application in patients with renal impairment as well as different advantages and disadvantages.
    [Abstract] [Full Text] [Related] [New Search]